Local study confirms safety, efficacy of Cardura XL

The Korean Urological Association said in its recent issue that a local study affirmed that Pfizer Korea's Cardura XL (doxazosin mesylate) is safe and effective for its indications of high blood pressure and benign prostatic hyperplasia in Korean patients.

The association further noted that Cardura XL did not exhibit any clinically significant antihypertensive action on BPH patients with nor...